文献速递乳腺

美国癌症联合委员会乳腺癌分期系统第八版:放射科医生需要了解的内容

American Joint Committee on Cancer's Staging System for Breast Cancer, Eighth Edition: What the Radiologist Needs to Know.
PubMed 文献 · Radiographics · 2018-09-28

本文回顾美国癌症联合委员会(AJCC)乳腺癌分期第八版的主要变化,该版于2018年1月1日全球采用,首次将肿瘤分级、激素受体与癌基因表达、多基因面板复发评分等预后生物标志物与解剖学信息整合,得出最终预后分期组,以更准确预测个体化临床结局和治疗反应;文章同时复习解剖学TNM分期、介绍预后生物标志物与预后分期,并指出可能改变临床管理的关键病变部位。

要点

  • 第八版AJCC乳腺癌分期于2018年1月1日全球采用,核心变化是纳入预后生物标志物生成最终预后分期组。
  • 预后因素包括肿瘤分级、激素受体与癌基因表达、多基因面板复发评分,与解剖学信息整合后用于个体化预后分层。
  • 放射科医生需熟悉解剖学TNM分期及可能改变临床管理的关键病变部位。

核心结论

  • 第八版AJCC乳腺癌分期将预后生物标志物与解剖学信息整合为最终预后分期组,较既往仅依赖解剖学分期能更好进行患者预后分层。

研究设计与样本

  • 本文为综述,回顾AJCC第八版乳腺癌分期的主要变化、解剖学TNM分期、预后生物标志物与预后分期,并识别可能改变临床管理的关键病变部位。

诊断标准与关键数值

  • 第八版AJCC乳腺癌分期纳入肿瘤分级、激素受体与癌基因表达、多基因面板复发评分等预后因素,与解剖学信息整合后得出最终预后分期组。

临床应用与阅片要点

  • 放射科医生应熟悉解剖学TNM分期、预后生物标志物及预后分期,并识别可能改变临床管理的关键病变部位。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

The TNM staging system for cancer was developed by Pierre Denoix in France in the 1940s and 1950s. The North American effort to standardize the TNM system for cancer staging was first organized in 1959 as the American Joint Committee for Cancer Staging and End-Results Reporting, which is now the American Joint Committee on Cancer (AJCC). The most recent edition of the AJCC Cancer Staging Manual, the eighth edition, was globally adopted on January 1, 2018. Previous editions of the manual have relied on anatomic methods of staging alone, which used population-based survival data to predict clinical outcomes. In the era of precision medicine, the major change in the eighth edition is the incorporation of prognostic biomarkers to more accurately predict clinical outcomes and treatment response on an individual basis, without relying solely on the anatomic extent of disease. Factors such as tumor grade, hormone receptor and oncogene expression, and multigene panel recurrence scores are now integrated with anatomic information to yield a final prognostic stage group, which will provide better stratification of patient prognosis. The purpose of this article is to review the major changes in the AJCC eighth edition for breast cancer staging, review anatomic TNM staging, familiarize the radiologist with prognostic biomarkers and prognostic staging, and identify key sites of disease that may alter clinical management. ©RSNA, 2018.

来源:Radiographics,查看原文。版权归原作者所有。

引用

  1. Kalli S, Semine A, Cohen S, et al. American Joint Committee on Cancer's Staging System for Breast Cancer, Eighth Edition: What the Radiologist Needs to Know. Radiographics. 2018. PMID: 30265613. doi:10.1148/rg.2018180056

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。